What is the price target for AVEO stock?
10 analysts have analysed AVEO and the average price target is 15.3 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 15.
AVEO PHARMACEUTICALS INC (AVEO) Forecast, Price Target & Analyst Ratings
NASDAQ:AVEO • US0535883070
Current stock price
15 USD
0 (0%)
At close:
15 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVEO PHARMACEUTICALS INC (AVEO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 13, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.05
- Revenue Estimate
- 36.075M
Price Target Details & History
Consensus Price Target and Range
Mean target
$15.30
Upside
+ 2.00%
From current price of $15.00 to mean target of $15.30, Based on 10 analyst forecasts
Low
$15.15
Median
$15.30
High
$15.75
Price Target Revisions
1 Month
0.00%
3 Months
-3.85%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for AVEO. The average price target is 15.3 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 15.
The average price target has been revised downward by 3.85% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
AVEO was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about AVEO.
In the previous month the buy percentage consensus was at a similar level.
AVEO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-08 | Stifel | Downgrade | Buy -> Hold |
| 2022-10-31 | JonesTrading | Downgrade | Buy -> Hold |
| 2022-10-24 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-10-19 | Baird | Downgrade | Outperform -> Neutral |
| 2022-10-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-07-12 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-11 | SVB Leerink | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 13, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.05
- Revenue Estimate
- 36.075M
- Revenue Q2Q
- 104.44%
- EPS Q2Q
- 77.33%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
2.59%
EPS (1 Month)
0.00%
EPS (3 Months)
56.59%
Next Earnings Summary
AVEO is expected to report earnings on 3/13/2023. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 36.08M USD.
The next earnings revenue estimate has been revised upward by 2.59% in the past 3 months.
Full Analyst Estimates 2022 - 2024
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.8M 433.33% | 6M -79.17% | 42.295M 604.92% | 114.29M 170.22% | 184.75M 61.65% | 233.91M 26.61% | |
| EBITDA YoY % growth | N/A | -38.88M | -49.487M -27.28% | N/A | N/A | N/A | |
| EBIT YoY % growth | -400K 98.47% | -38.9M -9,625.00% | -49.554M -27.39% | -19.178M 61.30% | 26.605M 238.73% | 58.329M 119.24% | |
| Operating Margin | -1.39% | -648.33% | -117.16% | -16.78% | 14.40% | 24.94% | |
| EPS YoY % growth | 0.62 224.00% | -1.71 -375.81% | -1.72 -0.58% | -0.69 59.87% | 0.55 179.31% | 1.32 140.99% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.05 77.33% |
| Revenue Q2Q % growth | 36.075M 104.44% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -1.476M 76.05% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
40.39%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
75.28%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
AVEO PHARMACEUTICALS INC / AVEO Forecast FAQ
What is the next earnings date for AVEO stock?
AVEO PHARMACEUTICALS INC (AVEO) will report earnings on 2023-03-13.
Can you provide the consensus estimates for AVEO PHARMACEUTICALS INC next earnings?
The consensus EPS estimate for the next earnings of AVEO PHARMACEUTICALS INC (AVEO) is -0.05 USD and the consensus revenue estimate is 36.08M USD.
What is the consensus rating for AVEO PHARMACEUTICALS INC (AVEO) stock?
The consensus rating for AVEO PHARMACEUTICALS INC (AVEO) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.